title: Effect of M2 muscarinic receptor blockade in rats with haloperidol-produced catatonic syndrome.
authors.affiliation: Laboratory of Biochemistry, Institute of Toxicology, Russian Ministry of Health, St. Petersburg.
authors.forename: S G
authors.initials: SG
authors.lastname: Dagaev
authors.forename: O A
authors.initials: OA
authors.lastname: Fil'ko
authors.forename: L G
authors.initials: LG
authors.lastname: Kubarskaya
authors.forename: A V
authors.initials: AV
authors.lastname: Khrabrova
authors.forename: L A
authors.initials: LA
authors.lastname: Mukovskii
authors.forename: R I
authors.initials: RI
authors.lastname: Glukhova
authors.forename: V I
authors.initials: VI
authors.lastname: Sanotskii
authors.forename: V B
authors.initials: VB
authors.lastname: Dolgo-Saburov
mesh_terms: D000818:Animals; D002375:Catalepsy / Q000139:chemically induced / Q000209:etiology*; D003517:Cyclopentanes / Q000494:pharmacology; D003959:Diamines / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D006220:Haloperidol; D008297:Male; D008333:Mandelic Acids / Q000494:pharmacology; D018727:Muscarinic Antagonists / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D043585:Receptor, Muscarinic M2 / Q000037:antagonists & inhibitors* / Q000502:physiology*; D013577:Syndrome; D014282:Trihexyphenidyl / Q000494:pharmacology
chemical_list: D003517:Cyclopentanes; D003959:Diamines; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D010880:Piperidines; D043585:Receptor, Muscarinic M2; C492521:pentifin; C016215:amedin; D014282:Trihexyphenidyl; D006220:Haloperidol; C054938:methoctramine; D004298:Dopamine